Ileus and Intra-Abdominal Hypertension due to Phosphate- Containing Enema

Başak Akyildiz1, Meda Kondolot2, Ali Yikilmaz3

  • 1Department of Pediatric Intensive Care, Faculty of Medicine, University of Erciyes, 38039, Kayseri, Turkey. basaknurbesra@gmail.com.

Insights

Fleet enemas can cause serious complications like electrolyte imbalance. Monitoring intra-abdominal pressure (IAP) is crucial for managing abdominal distention in patients using phosphate enemas.

Area of Science:

  • Pediatric Gastroenterology
  • Nephrology
  • Critical Care Medicine

Background:

  • Fleet enemas, commonly used for constipation, carry risks including cardiac insufficiency, renal failure, and electrolyte disturbances.
  • Phenylketonuria (PKU) is a metabolic disorder that can be associated with chronic constipation.
  • Phosphate enemas can lead to severe hyperphosphatemia and hypocalcemia, especially in susceptible individuals.

Observation:

  • A 7-year-old girl with PKU and constipation presented with seizures, vomiting, and abdominal distention after receiving a fleet enema.
  • Initial laboratory findings revealed hypocalcemia and hyperphosphatemia, with ECG showing a prolonged QT interval.
  • Progressive abdominal distention led to elevated intra-abdominal pressure (IAP) of 19.5 mmHg, prompting intervention.

Findings:

  • Treatment with gastric and colonic decompression, along with intravenous calcium gluconate, resulted in clinical stabilization.
  • Serum calcium and phosphorus levels normalized (8.8 mg/dl and 4.0 mg/dl, respectively) within 2 days.
  • Abdominal distention resolved, with a subsequent IAP measurement of 3.5 mmHg.

Implications:

  • Intra-abdominal pressure (IAP) monitoring serves as a valuable tool for assessing and managing progressive abdominal distention in patients treated with phosphate enemas.
  • This case highlights the potential severity of fleet enema complications, particularly in pediatric patients with underlying metabolic conditions.
  • Early recognition and management of electrolyte imbalances and increased IAP are critical for favorable outcomes.

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
850
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
830
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.4K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
727
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K